Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 044414/0672 | |
| Pages: | 32 |
| | Recorded: | 11/09/2017 | | |
| Attorney Dkt #: | 31899-36988/US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/16/2019
|
Application #:
|
15587270
|
Filing Dt:
|
05/04/2017
|
|
Publication #:
|
|
Pub Dt:
|
01/25/2018
| | | | |
|
Title:
|
5-[[4-[[Morpholin-2-yl]Methylamino]-5-(Trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-Carbonitrile and Therapeutic Uses Thereof
|
|
|
Assignee
|
|
|
|
|
| ANGEL BUILDING, 407 ST JOHN STREET |
| LONDON, UNITED KINGDOM EC1V 4AD |
|
|
Correspondence name and address
|
| |
MARK KINCH
|
| |
FENWICK & WEST LLP
|
| |
801 CALIFORNIA STREET
|
| |
MOUNTAIN VIEW, CA 94041
|
Search Results as of:
06/20/2024 09:59 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
